StockGlow

Immutep Limited (PRRUF)

Develops cancer immunotherapy drugs that activate the immune system to fight tumors.

$0.05+0.00%Healthcare
Compare PRRUF with
StockGlow Score
22
Leaning Bearish
BearishBullish
1 year ago-73.7%

The outlook

PRRUF is trading near its 52-week lows at $0.05, with mixed momentum against its moving averages. Analyst coverage appears limited, and the overall sentiment leans bearish based on current market data.

What’s behind the score

Price trendMixed vs its moving averages
52-week range3% of the way from its 52-week low to high
Market cap
$73.7M
52-wk high
$0.33
52-wk low
$0.04
50-day avg
$0.05
200-day avg
$0.15
Trailing P/E
—

Similar stocks

IMMPImmutep Limited$0.38-1.68%MAPTMaptelligent, Inc.$0.00+0.00%GCPEFGCL Technology Holdings Limited$0.10+11.11%CRWOFChina Railway Group Limited$0.65+45.93%DFIFFDFR Gold Inc.$0.01+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy